{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:09:54Z","timestamp":1740164994387,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004847","name":"Zahedan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.msard.2024.105913","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T06:30:48Z","timestamp":1727677848000},"page":"105913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of brimonidine on visual indices in patients with acute optic neuritis: A single blind randomized clinical trial"],"prefix":"10.1016","volume":"91","author":[{"given":"Mohammed","family":"Arish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meisam","family":"Sargazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Sedigh","family":"Dakkali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepide","family":"Mohammadzamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeid","family":"Rasouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Asani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2024.105913_bib0001","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/NRL.0b013e31816f27fe","article-title":"Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations","volume":"14","author":"Abou Zeid","year":"2008","journal-title":"Neurologist."},{"key":"10.1016\/j.msard.2024.105913_bib0002","first-page":"103","article-title":"Chromatic performance of high index plastic optical materials","volume":"8","author":"Aristeidis","year":"2021","journal-title":"J. Mater. Sci."},{"issue":"1","key":"10.1016\/j.msard.2024.105913_bib0003","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9394(03)00862-6","article-title":"Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial","volume":"137","author":"Beck","year":"2004","journal-title":"Am. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.msard.2024.105913_bib0004","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis. Experience of the optic neuritis treatment trial","volume":"101","author":"Beck","year":"1994","journal-title":"Ophthalmology."},{"issue":"9","key":"10.1016\/j.msard.2024.105913_bib0005","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1007\/s11999-008-0346-9","article-title":"Statistics in brief: the importance of sample size in the planning and interpretation of medical research","volume":"466","author":"Biau","year":"2008","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.msard.2024.105913_bib0006","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.msard.2018.04.006","article-title":"Frequent retinal ganglion cell damage after acute optic neuritis","volume":"22","author":"Brandt","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.msard.2024.105913_bib0007","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00415-017-8531-y","article-title":"Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis","volume":"264","author":"Britze","year":"2017","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105913_bib0008","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pathophys.2010.04.009","article-title":"Optic neuritis: a mechanistic view","volume":"18","author":"Burton","year":"2011","journal-title":"Pathophysiology."},{"key":"10.1016\/j.msard.2024.105913_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.705405","article-title":"Brimonidine is neuroprotective in animal paradigm of retinal ganglion cell damage","volume":"12","author":"Conti","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.msard.2024.105913_bib0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/opo.12310","article-title":"The good (logMAR), the bad (Snellen) and the ugly (BCVA, number of letters read) of visual acuity measurement","volume":"36","author":"Elliott","year":"2016","journal-title":"Ophthalmic. Physiol. Opt."},{"issue":"1","key":"10.1016\/j.msard.2024.105913_bib0011","first-page":"21","article-title":"The reliability of the Pelli-Robson contrast sensitivity chart","volume":"10","author":"Elliott","year":"1990","journal-title":"Ophthalmic. Physiol. Opt."},{"issue":"3","key":"10.1016\/j.msard.2024.105913_bib0012","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1113\/jphysiol.1966.sp008107","article-title":"The contrast sensitivity of retinal ganglion cells of the cat","volume":"187","author":"Enroth-Cugell","year":"1966","journal-title":"J. Physiol."},{"issue":"5","key":"10.1016\/j.msard.2024.105913_bib0013","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ophtha.2017.01.005","article-title":"Retinal and Optic Nerve Degeneration in Patients with Multiple Sclerosis Followed up for 5 Years","volume":"124","author":"Garcia-Martin","year":"2017","journal-title":"Ophthalmology."},{"issue":"10","key":"10.1016\/j.msard.2024.105913_bib0014","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/1352458513475722","article-title":"Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis","volume":"19","author":"Graves","year":"2013","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2024.105913_bib0015","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","author":"Group","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2024.105913_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2015.02.059","article-title":"Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis","volume":"592","author":"Guo","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.msard.2024.105913_bib0017","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.exer.2008.02.008","article-title":"Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments","volume":"86","author":"Hern\u00e1ndez","year":"2008","journal-title":"Exp. Eye Res."},{"year":"2013","series-title":"Introduction to mathematical statistics","author":"Hogg","key":"10.1016\/j.msard.2024.105913_bib0018"},{"key":"10.1016\/j.msard.2024.105913_bib0019","series-title":"StatPearls","article-title":"Contrast Sensitivity","author":"Kaur","year":"2024"},{"issue":"1","key":"10.1016\/j.msard.2024.105913_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-6-4","article-title":"Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons","volume":"6","author":"Lambert","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.msard.2024.105913_bib0021","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.msard.2016.10.009","article-title":"Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis","volume":"10","author":"Longbrake","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2024.105913_bib0022","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ajo.2008.08.005","article-title":"Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model","volume":"147","author":"Ma","year":"2009","journal-title":"Am. J. Ophthalmol."},{"year":"2021","series-title":"2021-2022 basic and clinical science course, section 12: retina and vitreous","author":"McCannel","key":"10.1016\/j.msard.2024.105913_bib0023"},{"issue":"9","key":"10.1016\/j.msard.2024.105913_bib0024","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.clinph.2018.06.012","article-title":"Retinal ganglion cell function in recovered optic neuritis: faster is not better","volume":"129","author":"Monsalve","year":"2018","journal-title":"Clin. Neurophysiol."},{"issue":"12","key":"10.1016\/j.msard.2024.105913_bib0025","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1007\/s00417-022-05720-8","article-title":"Memantine administration in patients with optic neuritis: a double blind randomized clinical trial","volume":"260","author":"Motamedi","year":"2022","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"issue":"4","key":"10.1016\/j.msard.2024.105913_bib0026","doi-asserted-by":"crossref","first-page":"A82","DOI":"10.1364\/JOSAA.31.000A82","article-title":"Chromatic visual evoked potentials in young patients with demyelinating disease","volume":"31","author":"Pompe","year":"2014","journal-title":"J. Opt. Soc. Am. a Opt. Image Sci. Vis."},{"issue":"3","key":"10.1016\/j.msard.2024.105913_bib0027","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","article-title":"Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Raftopoulos","year":"2016","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.msard.2024.105913_bib0028","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1167\/iovs.02-1100","article-title":"How sensitive to clinical change are ETDRS logMAR visual acuity measurements?","volume":"44","author":"Rosser","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.msard.2024.105913_bib0029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/iovs.63.2.27","article-title":"Identifying the retinal layers linked to human contrast sensitivity via deep learning","volume":"63","author":"Shamsi","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.msard.2024.105913_bib0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9394(14)75429-7","article-title":"Contrast sensitivity and other vision tests in the optic neuritis treatment trial","volume":"121","author":"Trobe","year":"1996","journal-title":"Am. J. Ophthalmol."},{"issue":"Suppl 3","key":"10.1016\/j.msard.2024.105913_bib0031","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1016\/S0039-6257(01)00205-3","article-title":"Retinal ganglion cell death induced by retinal ischemia. neuroprotective effects of two alpha-2 agonists","volume":"45","author":"Vidal-Sanz","year":"2001","journal-title":"Surv. Ophthalmol."},{"issue":"2","key":"10.1016\/j.msard.2024.105913_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1756285611398702","article-title":"Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis","volume":"4","author":"Voss","year":"2011","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"12","key":"10.1016\/j.msard.2024.105913_bib0033","first-page":"2849","article-title":"Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension","volume":"42","author":"WoldeMussie","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.msard.2024.105913_bib0034","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1167\/iovs.61.6.40","article-title":"Relationship between acuity and contrast sensitivity: differences due to eye disease","volume":"61","author":"Xiong","year":"2020","journal-title":"Investigat. Opthalmol. Visual Sci."},{"issue":"9","key":"10.1016\/j.msard.2024.105913_bib0035","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s10072-020-04360-2","article-title":"Effect of phenytoin on retinal ganglion cells in acute isolated optic neuritis","volume":"41","author":"Yadegari","year":"2020","journal-title":"Neurol. Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T04:31:34Z","timestamp":1732336294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824004899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"alternative-id":["S2211034824004899"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105913","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of brimonidine on visual indices in patients with acute optic neuritis: A single blind randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105913"}}